Zealand Pharma A/S (ZEAL) — Long-term Investment Intensity
Zealand Pharma A/S (ZEAL) has a Long-term Investment Intensity of 1.6% as of March 2022. Long-term investments of Dkr29.74 Million represent 1.6% of total assets of Dkr1.84 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Zealand Pharma A/S investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Zealand Pharma A/S Long-term Investment Intensity (2017–2021)
This chart shows how Zealand Pharma A/S's Long-term Investment Intensity has evolved across 5 annual periods from 2017 to 2021. As of March 2022, the intensity stands at 1.6%, reflecting long-term investments of Dkr29.74 Million against total assets of Dkr1.84 Billion DKK. Explore Zealand Pharma A/S cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Zealand Pharma A/S (2017–2021)
The table below presents the year-by-year Long-term Investment Intensity for Zealand Pharma A/S from 2017 to 2021, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ZEAL stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (DKK) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 1.3% | Dkr26.91 Million | Dkr2.07 Billion | ▼ -3.6 pp |
| 2020 | 4.9% | Dkr94.56 Million | Dkr1.92 Billion | ▲ +2.7 pp |
| 2019 | 2.2% | Dkr35.63 Million | Dkr1.60 Billion | ▼ -0.4 pp |
| 2018 | 2.6% | Dkr32.58 Million | Dkr1.23 Billion | ▲ +1.4 pp |
| 2017 | 1.3% | Dkr9.31 Million | Dkr737.24 Million | — |